Chris Parry on InMedInMed Pharmaceuticals (
CSE:C.IN,
Stock Forum) takes basic approved pharma data and runs it through an exclusive tech platform that figures out what elements of those approved therapies can be found in medical marijuana, as a fast track to MMJ-based therapies. That’s not even weed-tech, that’s weed-tech-health… a triple threat if ever there was one.